Abstract-Sepsis and hyperglycemia are highly associated with increases in mortality rates, particularly in the critically ill patients. Sepsis diagnosis has been proven challenging due to delay in getting the blood culture results. Thus, often clinical experiences overrule the protocol to prevent the worsening outcome of the patients. In some cases, the erroneous clinical judgement cause antibiotic resistance and even adverse clinical outcomes. This paper investigates the correlation between two parameters; insulin sensitivity and blood glucose level among sepsis patients. The blood glucose level is measured at the bedside during the patient's stay, whereas insulin sensitivity is obtained using the validated glucose-insulin model. Thus, the insulin sensitivity is a specific parameter of the patient, unregimented of the protocol given to the patient. The same parameters, blood glucose and insulin sensitivity, are also compared to the non-sepsis patients to establish a relationship that can be used for sepsis diagnosis. Given the availability of these two parameters that can be captured rapidly and instantly, a significant relationship can, therefore, help clinicians to identify sepsis at an early stage without secondguessing.
I. INTRODUCTION
Sepsis is a clinical condition classified as an organ dysfunction with the manifestation of the dysregulated host response to infection. It is very common in critical care especially the Intensive Care Unit (ICU) with a vast number of deaths. In Malaysia, sepsis is reported as the most common diagnoses leading to the ICU admission with 42.3% mortality in severe sepsis [1] . It is also the most prominent causes of death worldwide. By 2020, sepsis cases are estimated to reach 2 million in the United States [2] .
For clinical management operation, organ dysfunction is assessed by the increment in SOFA (sequential organ failure assessment) of at least 2 points. Septic shock is identified as a requirement of vasopressor to maintain the MAP (mean arterial pressure) of at least 65 mmHg [3] . The mortality risk of septic shock is higher compared to sepsis, while refractory septic shock is categorized as the highest risk. Each sepsis category is defined based on the ACCP-SCCM guidelines established during the consensus conference on sepsis and organ failure.
Even with a standard guideline to identify sepsis, patients with suspected infection are likely to receive treatment before blood culture result is obtained. This is because early treatment is crucial in sepsis as it profoundly influences the patient's condition and outcome. Therefore, in reality clinician intervention and early treatment of sepsis often overrule the blood investigation.
High level of counter-regulatory hormones such as glucocorticoids is released in sepsis that cause increased hepatic gluconeogenesis and insulin resistance [4] [5] [6] . Additionally, significant success in sepsis occurrence has been reported due to the implementation of blood glucose control. The effectiveness of model-based glucose control has been proven in a number of studies, particularly on the critically ill patients [7] [8] [9] .
In model-based glucose control, the patient's specific and patient's dynamic parameters such as insulin sensitivity, secretion sensitivity or other unique parameter can be identified. These parameters are obtained by fitting the actual clinical data into the glucose-insulin model. The specific parameters denote the physiological response of the patient towards the treatment regardless of the blood glucose control protocol used on the patients [10, 11] .
This study is aimed to capture the insulin sensitivity profiles of the sepsis patients and identify its correlation with the blood glucose levels. Additionally, the insulin sensitivity profiles of the sepsis cohort and non-sepsis cohort will be analyzed to determine the significance level. This clinical information will be used to identify the interrelationship of insulin sensitivity profile with the sepsis condition of a patient and thus, can potentially provide an early insight into the patient's condition.
II. METHODOLOGY

A. Glucose-Insulin Model
Insulin sensitivity profiles of the patients are determined using the Intensive Control Insulin Nutrition Glucose (ICING) model. This model has been clinically validated from some studies [12, 13] . The equations of the model are defined in (1) to (7) . The parameters of the model are simplified in Table I .
B. Clinical Data
Clinical data were obtained from the retrospective data of the patients admitted to the Universiti Malaya Medical Centre (UMMC). Sepsis patients were selected based on the clinical judgement of their blood culture results. These patients were treated with glycemic control of the UMMC protocol.
There were 27 patients selected for this analysis. Table II summarizes the demographics of the sepsis and non-sepsis patients selected in this study. 23 patients are male and 4 patients are female. The non-sepsis cohort is slightly older compared to the sepsis cohort. SOFA score and SAPS (Simplified Acute Physiology Score) of the sepsis cohort are higher than the non-sepsis group. Blood glucose levels are measured at the bedside, either hourly, 2-hourly, 3-hourly and up to 8-hourly depending on the glycemic control protocol and the patient's condition.
Median blood glucose level of sepsis cohort is slightly higher than the non-sepsis cohort with a difference of 0.1 mmol/L. The median insulin rate given to the sepsis patients is higher with 2.2 U/hr, whereas non-sepsis patients received 1.5 U/hr. Median glucose rate received by sepsis patients is muchly lower compared to the non-sepsis patients with 0.8 g/hr and 3.8 g/hr, respectively. Total hours of treatment for sepsis patients is 1585 hours, whereas 1808 hours for the -5 L.min/mU for non-sepsis cohort. Fig. 1 shows the empirical cumulative distribution function of blood glucose for the sepsis and non-sepsis cohorts. The blood glucose distributions almost overlaid below 8.1 mmol/L. Interestingly, above 8.1 mmol/L, the blood glucose distribution of the sepsis cohort is shifted to the right compared to the non-sepsis cohort, indicating that sepsis cohort has higher blood glucose level. Fig. 2 shows the empirical cumulative distribution function of insulin sensitivity for the sepsis and non-sepsis cohorts. The distributions are separated for both cohorts, with a difference of 11.8x10 -5 L.min/mU. At the 25 th and 75 th percentile, the differences are 6.3x10 -5 L.min/mU, and 18.8x10 -5 L.min/mU, respectively. Fig. 3 shows the boxplot of blood glucose level perpatient for the non-sepsis and sepsis patients. Fig. 4 shows the boxplot of insulin sensitivity per-patient for both cohorts. Comparing the two groups, sepsis patients have a slightly higher blood glucose level individually and higher interquartile range. The insulin sensitivity distribution of the non-sepsis patients is more scatter compared to the sepsis patients. Half of the non-sepsis patients have higher median insulin sensitivity compared to the average median of insulin sensitivity for the sepsis patients. Thus, insulin sensitivity level of sepsis patients is considered lower than insulin sensitivity of non-sepsis patients, eventhough the blood glucose levels are not muchly different.
Statistical analysis was conducted to determine the association of blood glucose level and insulin sensitivity for each cohort. There is a very low and negative correlation between the two parameters; blood glucose level and insulin sensitivity of the sepsis patients (r=-0.284, p<0.01). Similarly, very low and negative correlation between blood glucose level and insulin sensitivity for the non-sepsis patients, (r=-0.265, p<0.01). Besides, statistical analysis indicates that there is a significant mean difference between the blood glucose level of non-sepsis patients and blood glucose level of sepsis patients (p<0.05). There is also a significant mean difference between insulin sensitivity of non-sepsis patients and insulin sensitivity of the sepsis patients using independent t-test (p<0.05).
This study presents the analysis of insulin sensitivity against blood glucose levels of critically ill patients that received insulin therapy during their ICU stay. In particular, these parameters, insulin sensitivity and blood glucose are compared between sepsis and non-sepsis patients. The objective of this study is to identify the relationship between these parameters that may potentially contribute towards the process of sepsis diagnosis. From this study, it shows that there is a relationship between blood glucose and insulin sensitivity. As the blood glucose level increases, insulin sensitivity decreases. There is a negative correlation as carried out using Pearson correlation. However, the correlation is very low. The negative correlation between insulin sensitivity and blood glucose level is also supported based on per-patient analysis as shown in Figures 3-4 . Both insulin sensitivity and blood glucose levels are significantly different between the two cohorts. Nevertheless, sepsis patients have much lower insulin sensitivity compared to the non-sepsis patients.
The finding of this study is in agreement with another previous research that has been conducted on different cohorts using unalike insulin therapy protocol [14] [15] [16] [17] . Thus, it indicates that the insulin sensitivity profiles generated using the glucose-insulin model are independent of the insulin protocol adapted and represent the specific parameter of these patients. In one of the study, the median range of sepsis patients of Christchurch Hospital was 4.1x10 -5 L.min/mU to 2.4x10 -5 L.min/mU [16] . Hence, this study proved that insulin sensitivity among sepsis patients is much smaller and potentially getting even lower at a more severe level of sepsis, such as septic shock and refractory septic shock.
Further analysis is still required with a more significant number of patients, several levels of sepsis group, and across different centers to establish a concrete relationship between insulin sensitivity, blood glucose levels and sepsis. More important, it must be based on a standardize definition of sepsis evolution. However, in the process of monitoring the sepsis condition, insulin sensitivity can therefore become a precursor for predicting the sepsis progression.
IV. CONCLUSION
Managing sepsis in clinical settings is very difficult, due to the complexity of sepsis itself. Often sepsis has been diagnosed based on clinical experience rather than blood culture results. This process consumes much time and eventually may worsen the condition of the patient, and thus the efficacy of the treatment. Hence, a precursor or marker for sepsis is necessary for clinical settings to avoid adjournment of treatment.
